ROTHSCHILD & CO ASSET MANAGEMENT US INC. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 189 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$8,337,000
+32.6%
136,604
+1.6%
0.11%
-5.3%
Q3 2020$6,285,000
-4.6%
134,439
+3.6%
0.11%
+16.5%
Q2 2020$6,585,000
+15.3%
129,787
+1.4%
0.10%
+9.0%
Q1 2020$5,710,000
+549.6%
127,994
+599.7%
0.09%
+888.9%
Q4 2019$879,000
+35.9%
18,293
-4.4%
0.01%
+28.6%
Q3 2019$647,000
-15.9%
19,140
+11.9%
0.01%
-12.5%
Q2 2019$769,000
+17.9%
17,097
-1.3%
0.01%
+14.3%
Q1 2019$652,000
-40.1%
17,325
-45.3%
0.01%
-46.2%
Q4 2018$1,088,000
-18.1%
31,692
+12.2%
0.01%
-7.1%
Q3 2018$1,328,00028,2530.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders